Prothena Corp Public (PRTA) Operating Margin Growth (3y) (2015 - 2026)

Prothena Corp Public (PRTA) Operating Margin Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prothena Corp Public 458.13 Mn 128.67 Mn - 265,561.00

Historic Data

Download Data
DateValue
Mar 31, 2026 265,561.00
Dec 31, 2025 -11.53 Mn
Sep 30, 2025 165,161.00
Jun 30, 2025 137,898.00
Mar 31, 2025 97,190.00
Dec 31, 2024 -23,330.00
Sep 30, 2024 -693,549.00
Jun 30, 2024 -231.00
Mar 31, 2024 -14.30 Mn
Dec 31, 2023 -1.64 Mn
Sep 30, 2023 1.97 Mn
Jun 30, 2023 1.21 Mn
Mar 31, 2023 1.50 Mn
Dec 31, 2022 909,126.00
Sep 30, 2022 691,238.00
Jun 30, 2022 778,268.00
Mar 31, 2022 904,997.00
Dec 31, 2021 890,583.00
Sep 30, 2021 961,691.00
Jun 30, 2021 2.27 Mn